$1.4B in Record Bookings Meets a 45% EPS Miss and a Guidance Walkback — The Demand Is Unquestionable, But BlueHalo's Margin Problem Just Got Louder

Results vs. Consensus

Quality of Miss

• Revenue (+2-3% beat): Revenue of $472.5M was a modest beat, driven by legacy organic growth accelerating to 21% ($227.4M, up from $219.5M Q1) and BlueHalo contributing $245.1M (up from $235.2M Q1). The revenue trajectory is healthy — but revenue isn't the problem. Profitability is.
• EPS (-44 to -49% miss): This is the headline and it's ugly. Non-GAAP EPS of $0.44 vs. $0.79-0.87 consensus represents the largest EPS miss since FY25 Q3's wildfire-driven shortfall. The miss stems from: (1) EBITDA declining 20% Q/Q ($45M vs. $56.6M) despite revenue growing, (2) higher-than-expected integration and ERP implementation costs, and (3) SCDE's continued margin weakness. This is not a one-time event like the Q3 FY25 wildfires — it's a structural margin issue in the acquired business.
• EBITDA (-20% Q/Q): The most alarming data point. Adjusted EBITDA declining from $56.6M to $45.0M while revenue grew from $454.7M to $472.5M means margins compressed ~230bps Q/Q (9.5% vs. 12.4%). This is the wrong direction for a company supposedly extracting integration synergies. Either the synergy timeline has lengthened or new costs have emerged that weren't in the Q1 raise.

Segment Performance

The AxS / SCDE Divergence Is Widening

AxS grew 6% Q/Q to $301.6M — the segment continues to execute. But SCDE was flat at $170.9M (vs. $169.4M Q1), and consolidated EBITDA declined from $56.6M to $45.0M. If we assume AxS maintained its Q1 margin (~18.5% EBITDA), AxS contributed ~$55.8M in EBITDA. That means SCDE's EBITDA was approximately ($10.8M) — a loss, not the $3.8M gain reported in Q1. SCDE went from barely profitable to loss-making in one quarter.

Assessment: The implied SCDE EBITDA deterioration is the single biggest concern in this report. If the BlueHalo segment is generating losses rather than low-single-digit margins, the accretion timeline extends further and the leverage math becomes more challenging. Management's Q1 confidence about integration being "ahead of schedule" looks increasingly premature.

The Bookings Story: $1.4B Is Extraordinary

Q2 bookings of $1.4B with a 2.9x book-to-bill ratio is one of the most impressive demand signals in the mid-cap defense space. This single quarter's bookings exceed the entire FY2025 total of $1.2B. The funded backlog at $1.1B with 93% revenue visibility means the revenue guide is essentially locked in — the risk is entirely on the margin side.

"AV is operating from a position of strength as evidenced by our record second quarter results, all-time high bookings and long-term contract wins." — Wahid Nawabi, CEO

Assessment: The demand thesis has never been stronger. 2.9x book-to-bill means order intake is nearly 3x revenue — this company has a capacity problem, not a demand problem. The Switchblade/Jump-20/LOCUST product cycle is in full acceleration mode, and global defense budgets are expanding. If AeroVironment can solve the margin problem, the revenue trajectory is a 5-year compounder.

Key Topics & Management Commentary

Overall Management Tone: Confident on demand, less convincing on margin. Nawabi led with "position of strength" and "all-time high bookings" — true but deflecting from the EPS miss. The guidance cut was framed as a modest adjustment, but coming one quarter after a 27% raise, it reads as a credibility wobble. The ERP implementation costs are a new headwind that wasn't in the Q1 narrative. The tone gap between Q1's "ahead of schedule" and Q2's reality suggests the integration honeymoon is over.

1. The Guidance Raise-Then-Cut: What Happened?

In Q1, management raised FY2026 non-GAAP EPS from $2.80-3.00 to $3.60-3.70 (+27%). In Q2, they lowered it to $3.40-3.55. The net change from the original guide is still positive (+$0.58 at midpoint, or +20%), but the sequential direction is negative. Management attributed the cut to higher-than-expected integration costs and ERP system implementation expenses. The GAAP net loss guide actually improved (($38M)-($30M) from ($77M)-($72M)), suggesting the non-cash amortization trajectory is better but the cash operating costs are worse.

Assessment: The raise-then-cut pattern is a credibility issue more than a fundamental one. The FY guide of $3.48 midpoint is still 20% above the original $2.90 — meaning BlueHalo is net-accretive, just less accretive than Q1's optimism suggested. The Street's 10%+ selloff overweights the cut vs. the still-positive net direction. However, if Q3 brings another cut, the pattern becomes a trend and the stock will face more significant derating.

2. EBITDA Declining While Revenue Grows: The Margin Problem

Adjusted EBITDA declined from $56.6M (Q1) to $45.0M (Q2) while revenue grew from $454.7M to $472.5M. This means EBITDA margin compressed from 12.4% to 9.5% — a 290bps Q/Q decline. In a company that should be extracting integration synergies and achieving operating leverage on 4% sequential revenue growth, margin compression of this magnitude is a red flag.

The likely culprits: (1) ERP implementation costs that were unanticipated at Q1, (2) SCDE margin deterioration (flat revenue with rising integration costs), and (3) potential one-time restructuring charges that management elected to include in non-GAAP numbers.

Assessment: The EBITDA trajectory needs to reverse in Q3 for the Outperform thesis to hold. If Q3 EBITDA stays at $45M or declines further, the FY $310M guide ($300-320M) becomes unreachable — it requires ~$110M/quarter average in Q3-Q4, which is 2.4x Q2's level. This implies a massive H2 step-up that is either seasonal (DoD fiscal year Q4 spending) or aspirational.

3. $1.4B Bookings: The Counter-Narrative

Every margin concern in this report must be weighed against the demand signal. $1.4B in single-quarter bookings — nearly 3x the quarterly revenue run-rate — is the kind of demand acceleration that defense investors dream about. This isn't just Switchblade: the breadth across loitering munitions, directed energy (LOCUST), and space systems suggests the combined platform is resonating with customers. At 93% revenue visibility to the FY guide midpoint, the revenue trajectory is among the most visible in the defense sector.

Assessment: The bookings validate the strategic rationale for BlueHalo even if the financial integration is messier than expected. A company with 2.9x book-to-bill and accelerating organic growth (21%) has the luxury of time to fix margin issues. The demand runway provides cover for 2-3 more quarters of integration noise before investors lose patience.

Guidance & Outlook

Implied H2 ramp: H1 non-GAAP EPS: $0.76 ($0.32 + $0.44). FY guide midpoint: $3.48. H2 needs: $2.72 (~$1.36/quarter). This is a 3.1x step-up from Q2's $0.44 — aggressive even with seasonal DoD spending patterns. H1 EBITDA: $101.6M ($56.6M + $45.0M). FY guide midpoint: $310M. H2 needs: $208.4M (~$104M/quarter) — a 2.3x step-up from Q2. These ramps are achievable if SCDE margins recover and AxS benefits from seasonal Q3-Q4 DoD spending, but leave minimal room for further integration friction.

What They're NOT Saying

1. SCDE segment EBITDA: No segment-level EBITDA was disclosed in Q2 (Q1 provided AxS $52.8M / SCDE $3.8M). The omission, when consolidated EBITDA declined 20% Q/Q, suggests SCDE's margin deteriorated and management doesn't want to highlight it.
2. ERP implementation timeline and cost: Cited as a driver of the guidance cut but not quantified. Is this a 2-quarter headwind or a 4-quarter headwind? The market needs specifics.
3. Why they raised in Q1 then cut in Q2: No explicit explanation for the guidance whiplash. What changed in the 90 days between the raise and the cut?
4. BlueHalo synergy targets: Still no formal synergy disclosure two quarters after close. Without targets, the market can't assess whether the integration is on track or behind.

Market Reaction

• Pre-earnings: ~$284
• After-hours: dropped to ~$251 (-12%)
• Following sessions: continued selloff, 10%+ total decline

The 10%+ selloff erased ~$1.6B in market cap and marks the second time in four quarters that AVAV has dropped 10%+ on earnings (FY25 Q3: -18%). The pattern is troubling: the stock rallies between earnings on the demand narrative (backlog, bookings, LMS growth) then sells off when profitability disappoints. This creates a "demand premium, margin discount" dynamic where the market wants to pay for the revenue story but keeps getting punished by the earnings execution. Breaking this cycle requires Q3 to deliver both revenue growth AND EBITDA expansion simultaneously.

Street Perspective

Debate: Is the Selloff an Opportunity or a Pattern?

Bull view: $1.4B in bookings at 2.9x book-to-bill is the strongest demand signal in mid-cap defense. Legacy organic growth at 21% is accelerating. The EPS miss is integration noise that will clean up in H2. At $255 post-selloff, you're buying the best backlog in defense at a de-rated multiple. This is FY25 Q3 all over again — buy the selloff.

Bear view: This isn't FY25 Q3. The Q3 miss was wildfires (one-time). This miss is BlueHalo margin failure (structural). EBITDA declined Q/Q on growing revenue — that's not noise, that's a business getting less profitable as it scales. The guidance raise-then-cut destroys credibility. And at $255, the stock still trades at 73x the lowered EPS — nowhere near cheap enough to compensate for execution uncertainty.

Our take: The bears have the near-term argument. A 45% EPS miss + guidance cut + Q/Q EBITDA decline is too much negative profitability data to dismiss as "integration noise." The demand story is genuinely extraordinary ($1.4B bookings), but demand without margin is revenue without profit. We need to see EBITDA inflect upward in Q3 before re-engaging. The FY25 Q3 playbook (buy the miss, wait for record Q4) worked because the miss was identifiably one-time; this miss has structural characteristics that may persist.

Model Update

Valuation: At ~$255 post-selloff (~$12.5B market cap on ~49M shares), AVAV trades at 73x FY2026E EPS ($3.48 mid), 40x FY2026E EBITDA ($310M), and 6.3x revenue. The EPS multiple is extremely elevated for a company with declining Q/Q margins and a guidance cut. On EBITDA, 40x is a premium but defensible IF the $310M guide is achievable (requires massive H2 ramp). Target revised to $200-240 (from $230-250), reflecting reduced confidence in near-term profitability. Would re-upgrade at $200-220 if Q3 shows EBITDA recovery.

Thesis Scorecard

Overall: The AVAV story has bifurcated: the demand picture is the best in the company's history (and arguably the best in mid-cap defense), but the profitability picture just took its second significant hit in four quarters. The core autonomous weapons thesis is intact and strengthening — Switchblade, Jump-20, and LOCUST are seeing accelerating adoption across global militaries. But the BlueHalo integration is proving bumpier than the Q1 optimism suggested, and the guidance raise-then-cut damages management's forecasting credibility at a critical moment.

Action: Downgrade to Hold from Outperform. The demand story deserves a premium, but not at 73x a declining EPS number. We need Q3 to deliver: (1) EBITDA recovery above $60M, (2) SCDE margin improvement, (3) stable or raised FY guidance. If all three are met, we'd re-upgrade to Outperform. If margins deteriorate further, we'd consider Underperform. At $200-220, the risk/reward would be more attractive.